- Home
- TMCI vs LAB Comparison
TMCI vs LAB Comparison
Compare TMCI & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMCI
- LAB
- Stock Information
- Founded
- TMCI 2014
- LAB 1999
- Country
- TMCI United States
- LAB United States
- Employees
- TMCI N/A
- LAB N/A
- Industry
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- TMCI Health Care
- LAB Industrials
- Exchange
- TMCI Nasdaq
- LAB Nasdaq
- Market Cap
- TMCI 371.1M
- LAB 372.1M
- IPO Year
- TMCI 2021
- LAB 2011
- Fundamental
- Price
- TMCI $6.18
- LAB $1.35
- Analyst Decision
- TMCI Hold
- LAB Buy
- Analyst Count
- TMCI 6
- LAB 2
- Target Price
- TMCI $9.18
- LAB $2.50
- AVG Volume (30 Days)
- TMCI 325.4K
- LAB 2.6M
- Earning Date
- TMCI 08-05-2025
- LAB 07-30-2025
- Dividend Yield
- TMCI N/A
- LAB N/A
- EPS Growth
- TMCI N/A
- LAB N/A
- EPS
- TMCI N/A
- LAB N/A
- Revenue
- TMCI $210,819,000.00
- LAB $169,687,000.00
- Revenue This Year
- TMCI $10.61
- LAB N/A
- Revenue Next Year
- TMCI $10.36
- LAB $12.18
- P/E Ratio
- TMCI N/A
- LAB N/A
- Revenue Growth
- TMCI 7.54
- LAB 33.86
- 52 Week Low
- TMCI $4.54
- LAB $0.92
- 52 Week High
- TMCI $10.79
- LAB $2.41
- Technical
- Relative Strength Index (RSI)
- TMCI 55.03
- LAB 64.54
- Support Level
- TMCI $5.54
- LAB $1.15
- Resistance Level
- TMCI $6.24
- LAB $1.31
- Average True Range (ATR)
- TMCI 0.31
- LAB 0.11
- MACD
- TMCI 0.09
- LAB 0.03
- Stochastic Oscillator
- TMCI 90.11
- LAB 57.89
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.